L&C BIO's largest shareholder Lee Hwan-chul's stake drops to 24.98% due to share increase; pledge agreements modified
L&C BIO's largest shareholder Lee Hwan-chul maintained his 6,738,328 shares as of June 23, 2026, but his ownership dropped from 27.12% to 24.98% due to an increase in total shares outstanding.
The filing shows Lee has pledged a total of 2,958,353 shares or 10.97% of the company with Korea Securities Finance and Kyobo Securities, with some contracts modified on June 22, 2026. Total loan balance is approximately 27 billion KRW.
This passive dilution from share issuance negatively impacts existing shareholder value. The large pledge positions also pose a risk of forced selling if stock prices decline.
[AI Summary]The largest shareholder's stake decline is a passive dilution from increased shares, weakening existing shareholder value. Substantial pledged shares signal leverage risk, potentially leading to margin calls or forced sales under price pressure. Investors should monitor the purpose of new share issuance and management stability.